Compound
US9975881B2 · kind B2 · utility
0Cited by
5References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 28, 2015 |
| Grant date | May 22, 2018 |
| Priority date | — |
| Expiry date | Dec 28, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D307/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided a compound which is (a) a pyrimidine sulfonamide of formula (I) or (b) a pharmaceutically acceptable salt thereof, crystalline forms of the compound, processes for obtaining the compound, pharmaceutical intermediates used in the manufacture of the compound, and pharmaceutical compositions containing the compound.The compound is useful in the treatment of a disease/condition in which modulation of chemokine receptor activity is beneficial.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.